WESTMINSTER, Colo., Aug. 09, 2021 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine...
SOUTH SAN FRANCISCO, Calif., Aug. 09, 2021 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST) (“Tempest”), a clinical-stage oncology company...
Top-line data from the pivotal GEM-3 study of B-VEC in dystrophic epidermolysis bullosa (“DEB”) on track for 4Q21Initiation of Phase...
Provides access to $30 million in capital contingent on FDA approval and U.S. market access for LibervantWARREN, N.J., Aug. 09,...
First Patient Dosed with RTX-240 in Combination with KEYTRUDA® (pembrolizumab) in Ongoing Phase 1/2 Clinical Trial for the Treatment of...
Outlines anticipated milestones related to its DIMI and SAMI devicesTORONTO, Aug. 09, 2021 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral”...
$200M received from BMS for anti-TIGIT bispecific antibody collaborationFDA cleared IND for AGEN1777 clinical enrollmentAGEN1181 rapidly advancing in the clinic;...
Mark Morgan Mark Morgan, SVP of Grail, newly appointed Board Member of Dante Labs CAMBRIDGE, United Kingdom, Aug. 09, 2021...
TORONTO, Aug. 09, 2021 (GLOBE NEWSWIRE) -- VitalHub Corp. (the “Company” or “VitalHub”) (TSXV: VHI) is pleased to announce it...
CAPLYTA supplemental new drug applications (sNDAs) for the treatment of bipolar depression are under review by the FDA, with a...
SANTA CLARA, Calif., Aug. 09, 2021 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and...
NEW YORK, Aug. 09, 2021 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment...
Groundbreaking ceremony to be streamed liveDURHAM, N.C., Aug. 09, 2021 (GLOBE NEWSWIRE) -- Heat Biologics, Inc. (“Heat”) (NASDAQ: HTBX), a...
Company to host conference call today at 8:00 AM Eastern NEW YORK, Aug. 09, 2021 (GLOBE NEWSWIRE) -- Axsome Therapeutics,...
Franklin, TN, Aug. 09, 2021 (GLOBE NEWSWIRE) -- Fuisz announces the issuance of US 11,076,642, entitled “Vaporizer for Smoking Cigarettes...
MELBOURNE, Australia, Aug. 09, 2021 (GLOBE NEWSWIRE) -- Opthea Limited (ASX:OPT; Nasdaq:OPT), a clinical stage biopharmaceutical company developing novel therapies...
ADMA Expands Commercial IG Product Offering with Additional BIVIGAM and NABI-HB Vial Sizes BIVIGAM 100 mL Vial and NABI-HB 1...
CAMBRIDGE, Mass., Aug. 09, 2021 (GLOBE NEWSWIRE) -- Trillium Therapeutics Inc. (NASDAQ/TSX: TRIL), a clinical stage immuno-oncology company developing innovative...
On track to initiate RECONNECT, a confirmatory pivotal trial of Zygel™ in patients with FXS, in the third quarter of...
Company to host conference call on Thursday, August 12th, 2021 at 8:00 a.m. ETCHESTERBROOK, Pa., Aug. 09, 2021 (GLOBE NEWSWIRE)...
